Patient-Focused Drug Development meeting with FDA – Twitter Conversation sent by Scott Gottlieb, the FDA Commissioner from:
Scott Gottlieb, M.D. @SGottliebFDA
#FDA will be hosting a Patient-Focused Drug Development meeting July 9 to obtain patients’ perspectives on the impacts of chronic pain, views on treatment approaches and challenges or barriers to accessing treatments.
This sounds promising to me. It seems like big step forward for pain patients, for the FDA Commissioner to publicly acknowledge that we exist and that opioids are necessary for some of us… quite a daring move in today’s opiophobic political atmosphere. Continue reading
OP-EDS: SHARE YOUR STORY – From the U.S. Pain Foundation.
The US Pain Foundation has put together a guide with tips for writing Op-Eds for your local newspapers:
Chronic pain is often misunderstood and stigmatized by the general public. U.S. Pain Foundation believes that, in order to create positive change in the perception of pain, people living with chronic pain must share their stories far and wide. Continue reading
I recently discovered that money, and thus influence, from the pharmaceutical industry has seeped into almost every national pain patient advocacy group, if not directly, then through intergroup relationships. Right on their public websites, it’s plain to see that “our” advocacy organizations are infested with pharmaceutical dollars.
Thanks to that irresistible money, the motivations of pain patient advocacy groups can be justifiably challenged: they could be pushing for pain patients’ rights to opioids only to generate more business for their “partners”, the pharmaceutical companies. (And, for all we know, this might even be true of some.)
I don’t mean to imply that these advocacy organizations aren’t doing much good for us, but there will be a limit on how far they can push any viewpoints that are contrary to the industry’s interests. I anticipate a direct conflict of interest when it comes to affordable (generic) pain medication. Continue reading
Patient Advocates Call on Brandeis to Fire Kolodny — Pain News Network – October 03, 2017 – By Pat Anson, Editor
A coalition of physicians, patient advocates and pain sufferers has written an open letter to Brandeis University asking for the dismissal of Andrew Kolodny, MD, a longtime critic of opioid prescribing who is co-director of opioid policy research at the university’s Heller School for Social Policy and Management.
Kolodny is the founder and Executive Director of Physicians for Responsible Opioid Prescribing (PROP), an anti-opioid activist group that has lobbied politicians and regulators for years to enact stronger measures to limit prescribing of opioid pain medication. Continue reading
This advocacy advice comes from Richard Lawhern, a tireless advocate for pain patients. He was a headline speaker at the “Stop the War on Chronic Pain Patients” rally in Wash DC last fall (See Making Ourselves Heard) and has personally contacted both journalists and legislators to fight the flood of anti-opioid articles and legislation.
I thought I would share some tactics that may help others be more effective in this kind of advocacy. Some of this is things I’ve heard. Some is what I’ve experienced myself.
- Physically visiting your own Senator’s office with an appointment to see a staff member by name is the most effective lobbying you can do without a checkbook and deep pockets. Senator’s constituents will always get priority over a non-resident. Continue reading
TAKE A STAND FOR PEOPLE LIVING WITH CHRONIC PAIN:
People with pain are misunderstood, inadequately treated, stigmatized and marginalized on a daily basis and are forgotten about.
Join People with Pain Matter and take action by advocating for nearly 100 million Americans afflicted with chronic pain.
This site offers a form into which you can write your story. The organization will then route it to all the people and places where it can do some good. Continue reading
Vilified and Coerced, Pain Patients are Desperate
In no other medical field are patients subject to such vilification, suspicion, and coercion as in pain management. Chronic pain patients have been abandoned in the blind rush to “protect” us from addiction to opioids, without concern for their legitimate use as pain relievers of last resort.
Those of us that require opiate medication for pain are treated like criminals. We must sign away our privacy and allow our medical records to be scrutinized by law enforcement, the DEA, or any third party private contractor working as a “drug warrior”. If we don’t sign, we don’t get treatment–this is blatant coercion.
Already struggling to make life worthwhile in my painfully broken body, I must now face additional hardship, expense, and obstacles legislated by my government.
Our culture seems to believe that simplistic moral solutions can solve complex social problems.
Applied to the problem of addiction to pain-relieving opioids, the response looks like this:
- Identify the “bad thing” (opioid drugs),
- declare war on it (War on Drugs),
- initiate a media campaign of misinformation (propaganda),
- take enforcement action (DEA raids),
- over-prosecute a few high profile cases (CVS, Walgreen’s, Pain Doctors),
- scare everyone else (legal threats), and
- then spend millions of our tax dollars (enforcement)
- forever (War on Drugs is still being fought after 30 years).
This creates a bureaucratic monster: Continue reading
Warning: This is a very angry essay about how the campaign against opioids could push someone to suicide.
I used to think I was the only one wrestling with these thoughts until I lately discovered other like-minded folks. I wasn’t sure whether to post it, but then I saw a question on the Inspire.com Pain and Pain Management forum about this very idea, and this is my answer:
Pushed Beyond Hope
Over the last few months, the accumulation of forces against opioid prescribing has pushed me over an edge, pushed me past my sense of self-preservation and into a fundamental shift of my expectations of life. Continue reading